A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF OZANIMOD, AN ORAL S1P RECEPTOR MODULATOR, IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF THE MAINTENANCE PERIOD OF THE TOUCHSTONE STUDY

William Sandborn  1     Brian G. Feagan  2     Douglas C. Wolf  3     Geert R. D'Haens  4     Severine Vermeire  5     Stephen B Hanauer  6     Subrata Ghosh  7     Heather Smith  8     Matt Cravets     Paul A. Frohna     Richard Aranda     Sheila Gujrathi     Allan Olson    
1 University of California,San Diego,United States
2 Robarts Research,London,Canada
3 Atlanta Gastroenterology Associates ,Atlanta,United States
4 Academic Medical Center,Amsterdam,Netherlands
5 University of Leuven,Leuven,Belgium
6 Feinberg School of Medicine,Chicago,United States
7 University of Calgary,Alberta,Canada
8 Receptos,San Diego,

Conference
UEG Week 2015

Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing